Clinical and biological basis of lung cancer prevention
Author(s)
Bibliographic Information
Clinical and biological basis of lung cancer prevention
（Respiratory pharmacology and pharmacotherapy）
Birkhäuser Verlag, c1998
Available at 1 libraries
Note
Includes bibliographical references and index
Description and Table of Contents
Description
This text seeks to strike a balance between considering public health approaches to tobacco control and population-based screening, advances in clinical evaluation of chemoprevention approaches, and the biology of lung carcinogenesis.
Table of Contents
- Prevention and early detection of lung cancer - clinical aspects, F.R. Hirsch, J.L. Mulshine
- smoking prevention and cessation, P. Tonnesen et al
- clinical pharmacology of vitamin A and retinoids, U. Pastorino, F. Formelli
- easy lung cancer detection, E. Brambilla
- molecular abnormalities in the sequential development of lung carcinoma, I.I. Wistuba, A.F. Gazdar
- application of In Situ PCR and In Situ hybridization to the characterization of lung cancers, A. Martinez
- tumour stroma formation in lung cancer, J-M. Vignaud et al
- tumour angiogenesis - basis for new prognostic factors and new anticancer therapies, D. Belotti, V. Castronovo
- cell cycle regulators and mechanisms of growth control evasion in lung cancer, I.E. Schauer, R.A. Sclafani
- molecular genetics of lung cancer, X.W. Wang et al
- neuropeptides, signal transduction and small cell lung cancer, M.J. Seckl, E. Rozengurt
- In Vitro analysis of bombesin/gastrin-releasing peptide receptor (bb2) ligand binding and G-protein coupling, G.S. Kroog et al
- DNA methylation changes in lung cancer, S.M. Hanash et al
- K-ras mutations as molecular markers of lung cancer, D.R. Jacobson
- seep lung adenomatosis - a model of virally induced lung cancer, C. Leroux et al
- retinoid acid receptor beta - an exploration of its role in lung cancer suppression and its potential in cancer prevention, A. Toulouse et al
- cytochrome P450 polymorphisms - risk factors for lung cancer? S. Benhamou, C. Bonaiti-Pellie
- glutathione S-tranferases and lung cancer risk, J. Seidegard
- the p53 tumour suppressor gene in lung cancer - from molecular to serological diagnosis, T. Soussi et al
- endoscopic localization of preneoplastic lung lesions, S. Lam, C.E. MacAulay
- antigen retrieval improves hnRNP A2/Bi immunohistological localization in premalignant lesions of the lung, M.S. Tockman et al
- molecular pathological mechanisms in NSCLC and the assessment of individuals with high risk of developing lung cancer, J.K. Field et al
- chemoprevention of lung cancer, U. Pastorino
- regional delivery of retinoids - a new approach to early lung cancer intervention, J.L. Mulshine et al
- natural inhibitors of carcinogenesis, H. Fujiki et al
- gene delivery to airways, C. Schatz, A. Pavirani
- lung cancer prevention - the point of a public health epidemiologist, A.J. Sasco
- biomarkers as intermediate endpoints in chemoprevention trials - biological basis of lung cancer prevention, V.A. Papadimitrakopoulou, W.K. Hong
- biological tools for mass screening, N. Martinet, M. Hogan
- optimization of the use of biological samples for the perspective evaluation of preneoplastic lesions, R. Gemmil et al.
by "Nielsen BookData"